DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Gross DJ, Munter G, Bitan M, Siegal T, Gabizon A, Weitzen R, Merimsky O, Ackerstein A, Salmon A, Sella A, Slavin S.
The role of imatinib mesylate (Glivec) for treatment of patients with malignant endocrine tumors positive for c-kit or PDGF-R.
Endocr Relat Cancer 2006; 13: 535-540
We do not assume any responsibility for the contents of the web pages of other providers.